In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...

Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal cancer (CRC).

To screen for colon and rectal cancers, most people have colonoscopies, which can feel invasive and require anesthesia, or they may take an at-home stool test, which can be more convenient but also ...

A next-generation multitarget stool DNA test, including assessments of DNA molecular markers and hemoglobin level, was developed to improve the performance of colorectal cancer screening, primarily ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the U.S. Food and Drug Administration (FDA) approved ...

50 million Americans due for colon cancer screening avoid it because they consider traditional tests so unpleasant. But now it can be as simple as a blood test. If you’re overdue for your colon cancer ...

Colorectal cancer is the third most diagnosed cancer in adults in the United States. Early detection could prevent more than 90% of colorectal cancer–related deaths, yet more than one third of the ...

A noninvasive colorectal cancer screening test that can be done at home could reduce the risk of colorectal cancer death by 33%, according to a new study. A noninvasive colorectal cancer screening ...

Credit: Guardant. The Shield blood test for colorectal cancer screening is a qualitative in vitro diagnostic test intended to detect colorectal cancer derived alterations in cell-free DNA from blood ...